How do US health care payers react to and use pharmacoeconomic information?
Year of publication: |
2011
|
---|---|
Authors: | Mullins, C. Daniel ; Ratner, Jonathan ; Ball, Daniel E. |
Published in: |
International journal of the economics of business. - Abingdon, Oxfordshire : Routledge, ISSN 1357-1516, ZDB-ID 1196953-2. - Vol. 18.2011, 2, p. 317-330
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Gesundheitsökonomik | Health economics | Kosten-Wirksamkeits-Analyse | Cost-effectiveness analysis | USA | United States | 1990-2008 |
-
Special issue: Pharmaceutical economics : essays in honor of Henry G. Grabowski
Mullins, C. Daniel, (2011)
-
Are biopharmaceutical budget caps good public policy?
Goldman, Dana P., (2016)
-
Understanding health outcomes and pharmacoeconomics
MacKinnon, George E., (2013)
- More ...
-
How Do US Health Care Payers React to and Use Pharmacoeconomic Information?
Mullins, C. Daniel, (2011)
-
How Do US Health Care Payers React to and Use Pharmacoeconomic Information?
Mullins, C. Daniel, (2011)
-
Colby, Margaret S., (2013)
- More ...